Revenue, 2023 (US$M)
$110.5
Forecast, 2030 (US$M)
$175.0
CAGR, 2024 - 2030
6.8%
Report Coverage
Sweden

Sweden blood cancer diagnostics market, 2018-2030 (US$M)

Sweden

Sweden blood cancer diagnostics market highlights

  • The Sweden blood cancer diagnostics market generated a revenue of USD 110.5 million in 2023 and is expected to reach USD 175.0 million by 2030.
  • The Sweden market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
  • In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
  • Research & Manufacturing is the most lucrative end use segment registering the fastest growth during the forecast period.


Blood cancer diagnostics market data book summary

Market revenue in 2023USD 110.5 million
Market revenue in 2030USD 175.0 million
Growth rate6.8% (CAGR from 2023 to 2030)
Largest segmentOutpatient facilities
Fastest growing segmentResearch & Manufacturing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHospitals, Outpatient Facilities, Research & Manufacturing
Key market players worldwideGE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Roche Holding AG, Qiagen NV, Becton Dickinson & Co, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, Hologic Inc, Koninklijke Philips NV, Illumina Inc


Other key industry trends

  • In terms of revenue, Sweden accounted for 1.1% of the global blood cancer diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany blood cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 644.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Blood Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website

Sweden blood cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood cancer diagnostics market will help companies and investors design strategic landscapes.


Outpatient facilities was the largest segment with a revenue share of 65.7% in 2023. Horizon Databook has segmented the Sweden blood cancer diagnostics market based on hospitals, outpatient facilities, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.


Sweden has been at the forefront of precision medicine initiatives, strongly emphasizing personalized treatment approaches. This drives the demand for advanced diagnostic tests identifying specific biomarkers and genetic mutations associated with blood cancer.


Blood Cancer awareness programs play a crucial role in educating public about the risks associated with prevalence and the importance of early detection. Hence, these programs are vital for reducing the incidence of blood cancer.

The Swedish government has launched several initiatives to improve cancer care, including the National Cancer Strategy and the Genomic Medicine Sweden initiative. These programs promote early detection, precision diagnostics, and personalized treatment for various cancers, including blood cancers.

Reasons to subscribe to Sweden blood cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Sweden blood cancer diagnostics market databook

  • Our clientele includes a mix of blood cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Sweden blood cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Sweden blood cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sweden blood cancer diagnostics market size, by end use, 2018-2030 (US$M)

Sweden Blood Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Sweden blood cancer diagnostics market size, by end use, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more